Aperture Investors’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-303,268
Closed -$11.9M 85
2023
Q2
$11.9M Sell
303,268
-276,183
-48% -$9.97M 1.42% 24
2023
Q1
$18.6M Sell
579,451
-109,295
-16% -$3.61M 2.58% 19
2022
Q4
$21.5M Buy
688,746
+159,645
+30% +$5.77M 3.5% 9
2022
Q3
$19.6M Buy
529,101
+16,043
+3% +$601K 3.21% 9
2022
Q2
$14.9M Buy
513,058
+30,812
+6% +$1.1M 2.49% 14
2022
Q1
$24.8M Buy
482,246
+262,185
+119% +$11.2M 3.21% 8
2021
Q4
$11.1M Buy
+220,061
New +$12.3M 1.43% 26

Other funds holding PGNY

Aperture Investors's PGNY Position: Q3 2023 in Review

Aperture Investors sold out of Progyny (PGNY) in Q3 2023, closing a stake of 303,268 shares — an estimated $11.9M sold.

Aperture Investors first reported a position in PGNY in Q4 2021 and held it in 7 quarters. The position peaked at $24.8M in Q1 2022. 321 funds tracked by Wall St. Rank hold PGNY as of Q3 2023.

  • Aperture Investors reported no remaining Progyny position as of Q3 2023 after selling out during the quarter.
  • Aperture Investors sold 303,268 Progyny shares in Q3 2023, an estimated $11.9M.
  • Aperture Investors first reported a position in Progyny in Q4 2021 and held it in 7 quarters.
  • Aperture Investors's Progyny position peaked at $24.8M in Q1 2022.
  • 321 funds tracked by Wall St. Rank held Progyny as of Q3 2023.

Based on Aperture Investors's 13F filing for Q3 2023, filed 14 Nov 2023.